287 related articles for article (PubMed ID: 15642421)
1. Reduction mammaplasty specimens and occult breast carcinomas.
Kakagia D; Fragia K; Grekou A; Tsoutsos D
Eur J Surg Oncol; 2005 Feb; 31(1):19-21. PubMed ID: 15642421
[TBL] [Abstract][Full Text] [Related]
2. Incidence of occult contralateral carcinomas of the breast following mastoplasty aimed at symmetrization.
Sorin T; Fyad JP; Pujo J; Colson T; Bordes V; Leroux A; Marchal F; Brix M; Simon E; Verhaeghe JL; Classe JM; Dolivet G
Ann Chir Plast Esthet; 2014 Apr; 59(2):e21-8. PubMed ID: 24530086
[TBL] [Abstract][Full Text] [Related]
3. Incidental atypical proliferative lesions in reduction mammoplasty specimens: analysis of 2498 cases from 2 tertiary women's health centers.
Desouki MM; Li Z; Hameed O; Fadare O; Zhao C
Hum Pathol; 2013 Sep; 44(9):1877-81. PubMed ID: 23656973
[TBL] [Abstract][Full Text] [Related]
4. Management of breast carcinoma identified intraoperatively during reduction mammaplasty.
Butler CE; Hunt KK; Singletary SE
Ann Plast Surg; 2003 Feb; 50(2):193-7. PubMed ID: 12567059
[TBL] [Abstract][Full Text] [Related]
5. Can magnetic resonance imaging be used to select patients for sentinel lymph node biopsy in prophylactic mastectomy?
McLaughlin SA; Stempel M; Morris EA; Liberman L; King TA
Cancer; 2008 Mar; 112(6):1214-21. PubMed ID: 18257089
[TBL] [Abstract][Full Text] [Related]
6. Surgical management of the patient with invasive carcinoma discovered at reduction mammoplasty.
Rudolph R; Niedbala AR
Am Surg; 2003 Nov; 69(11):1003-5. PubMed ID: 14627265
[TBL] [Abstract][Full Text] [Related]
7. [Therapeutic problems posed by sub-clinical breast cancers].
Espié M
Contracept Fertil Sex; 1999 Apr; 27(4):298-305. PubMed ID: 10349773
[TBL] [Abstract][Full Text] [Related]
8. Incidental atypical proliferative lesions in reduction mammoplasty specimens in patients with a history of breast cancer.
Li Z; Fadare O; Hameed O; Zhao C; Desouki MM
Hum Pathol; 2014 Jan; 45(1):104-9. PubMed ID: 24182561
[TBL] [Abstract][Full Text] [Related]
9. Intra-operative touch preparation cytology; does it have a role in re-excision lumpectomy?
Valdes EK; Boolbol SK; Cohen JM; Feldman SM
Ann Surg Oncol; 2007 Mar; 14(3):1045-50. PubMed ID: 17206481
[TBL] [Abstract][Full Text] [Related]
10. Nipple-sparing mastectomy in association with intra operative radiotherapy (ELIOT): A new type of mastectomy for breast cancer treatment.
Petit JY; Veronesi U; Orecchia R; Luini A; Rey P; Intra M; Didier F; Martella S; Rietjens M; Garusi C; DeLorenzi F; Gatti G; Leon ME; Casadio C
Breast Cancer Res Treat; 2006 Mar; 96(1):47-51. PubMed ID: 16261402
[TBL] [Abstract][Full Text] [Related]
11. Urban-rural differences in the management of screen-detected invasive breast cancer and ductal carcinoma in situ in victoria.
Kok DL; Chang JH; Erbas B; Fletcher A; Kavanagh AM; Henderson MA; Gertig DM
ANZ J Surg; 2006 Nov; 76(11):996-1001. PubMed ID: 17054549
[TBL] [Abstract][Full Text] [Related]
12. Lobular neoplasia. Long term risk of breast cancer and relation to other factors.
Bodian CA; Perzin KH; Lattes R
Cancer; 1996 Sep; 78(5):1024-34. PubMed ID: 8780540
[TBL] [Abstract][Full Text] [Related]
13. [Lobular carcinoma in situ (LCIS): risk factor and precursor of invasive lobular breast cancer].
Aulmann S; Penzel R; Schirmacher P; Sinn HP
Verh Dtsch Ges Pathol; 2007; 91():208-13. PubMed ID: 18314616
[TBL] [Abstract][Full Text] [Related]
14. Lobular carcinoma in situ of the breast.
Goldschmidt RA; Victor TA
Semin Surg Oncol; 1996; 12(5):314-20. PubMed ID: 8873318
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the relative incidence of impalpable invasive breast carcinoma and ductal carcinoma in situ in cancers detected in patients older and younger than 50 years of age.
Evans WP; Starr AL; Bennos ES
Radiology; 1997 Aug; 204(2):489-91. PubMed ID: 9240541
[TBL] [Abstract][Full Text] [Related]
16. Is routine sentinel lymph node biopsy indicated in women undergoing contralateral prophylactic mastectomy? Magee-Womens Hospital experience.
Soran A; Falk J; Bonaventura M; Keenan D; Ahrendt G; Johnson R
Ann Surg Oncol; 2007 Feb; 14(2):646-51. PubMed ID: 17122987
[TBL] [Abstract][Full Text] [Related]
17. Noninvasive breast cancer. The dilemma of the 1990s.
Silverstein MJ
Obstet Gynecol Clin North Am; 1994 Dec; 21(4):639-58. PubMed ID: 7731639
[TBL] [Abstract][Full Text] [Related]
18. Sentinel node procedure is warranted in ductal carcinoma in situ with high risk of occult invasive carcinoma and microinvasive carcinoma treated by mastectomy.
Tunon-de-Lara C; Giard S; Buttarelli M; Blanchot J; Classe JM; Baron M; Monnier B; Houvenaeghel G
Breast J; 2008; 14(2):135-40. PubMed ID: 18315691
[TBL] [Abstract][Full Text] [Related]
19. [Surgical treatment of carcinoma in situ of the breast].
Gangi S; Costanzo MP; Furci M; Khansa K; Basile F
Ann Ital Chir; 1995; 66(1):47-50; discussion 50-1. PubMed ID: 7668482
[TBL] [Abstract][Full Text] [Related]
20. Management of lobular neoplasia diagnosed by core needle biopsy: study of 52 biopsies with follow-up surgical excision.
Lavoué V; Graesslin O; Classe JM; Fondrinier E; Angibeau H; Levêque J
Breast; 2007 Oct; 16(5):533-9. PubMed ID: 17629481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
